CHAPEL HILL, NC, UNITED STATES - Jan 27, 2015 - WHAT:  Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services during the Outsourcing in Clinical Trials (OCT) West Coast conference, being held February 3-4 in Burlingame, California.

Event attendees are invited to stop by Rho’s booth (#71) to learn more about the services they provide to ensure an efficient and a successful drug development process. Rho focuses on helping pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services. These services include clinical operations, project management, data management, data standards, and biostatistics with extensive experience in many therapeutic areas. 

WHO: Rho experts at OCT:

• David Cass, Senior Director, Business Development

WHEN:  February 3-4, 2015

WHERE:  Hyatt Regency San Francisco Airport
Booth #71
1333 Bayshore Highway
Burlingame, California

DETAILS: For media inquiries please contact Bernadette Miller at Largemouth Communications, (703) 297-5992, bernadette@largemouthpr.com.

ABOUT:  Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 30 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.